Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia
- PMID: 32956601
- DOI: 10.7326/M20-4680
Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia
Abstract
Background: Strategies to improve patients' tolerance of and adherence to statins may enhance the effectiveness of dyslipidemia treatment in those at risk for cardiovascular disease (CVD).
Purpose: To assess the benefits and harms of interventions to improve statin adherence in patients at risk for CVD.
Data sources: MEDLINE, EMBASE, PubMed, and the Cochrane Library from December 2013 through May 2019 (English language only).
Study selection: Systematic reviews (SRs), randomized controlled trials (RCTs), and cohort studies that addressed interventions for improving statin tolerance and adherence.
Data extraction: One investigator abstracted data and assessed study quality, and a second investigator checked abstractions and assessments for accuracy.
Data synthesis: One SR, 1 RCT, and 4 cohort studies were included. The SR found that intensified patient care improved adherence and decreased levels of total serum cholesterol and low-density lipoprotein cholesterol (LDL-C) at 6 months or more of follow-up. Compared with statin treatment discontinuation, nondaily statin dosing lowered total cholesterol and LDL-C levels. One large cohort study suggested that more than 90% of patients who discontinued statin treatment could be rechallenged with the same or a different statin and be adherent 1 year after a statin-related adverse event led to discontinuation. Two small cohort studies reported that more than 90% of patients who were previously intolerant to statins and who had low baseline levels of vitamin D were able to adhere to statins 1 year after vitamin D supplementation.
Limitation: This is a qualitative synthesis of new evidence with existing meta-analyses, and studies had several methodological shortcomings.
Conclusion: Although the strength of evidence for most interventions was low or very low, intensified patient care and rechallenge with the same or a different statin (or a lower dose) seem to be favorable options for improving statin adherence.
Primary funding source: U.S. Department of Veterans Affairs.
Similar articles
-
Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-2. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-2. PMID: 27559556 Free Books & Documents. Review.
-
Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy: a systematic review.Ann Intern Med. 2014 Apr 1;160(7):468-76. doi: 10.7326/M13-2526. Ann Intern Med. 2014. PMID: 24514899 Review.
-
Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-1. PMID: 27559550 Free Books & Documents. Review.
-
Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.Ann Intern Med. 2020 Nov 17;173(10):822-829. doi: 10.7326/M20-4648. Epub 2020 Sep 22. Ann Intern Med. 2020. PMID: 32956597
-
Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.Ann Intern Med. 2009 Nov 3;151(9):622-30. doi: 10.7326/0003-4819-151-9-200911030-00144. Ann Intern Med. 2009. PMID: 19884623 Review.
Cited by
-
Role of the screening with coronary computed tomography angiography on lipid management and risk factors control in an asymptomatic Chinese population: a community-based, parallel-group, open-label, randomized clinical trial (RESPECT2).Trials. 2024 Sep 30;25(1):635. doi: 10.1186/s13063-024-08469-z. Trials. 2024. PMID: 39350195 Free PMC article.
-
The Effectiveness and Safety of Intensive Lipid-Lowering with Different Rosuvastatin-Based Regimens in Patients at High Cardiovascular Disease Risk: A Nonblind, Randomized, Controlled Trial.Rev Cardiovasc Med. 2023 Aug 1;24(8):222. doi: 10.31083/j.rcm2408222. eCollection 2023 Aug. Rev Cardiovasc Med. 2023. PMID: 39076713 Free PMC article.
-
Statins use amidst the pandemic: prescribing, dispensing, adherence, persistence, and correlation with COVID-19 statistics in nationwide real-world data from Poland.Front Pharmacol. 2024 Apr 9;15:1350717. doi: 10.3389/fphar.2024.1350717. eCollection 2024. Front Pharmacol. 2024. PMID: 38655185 Free PMC article.
-
What is the quantity, quality and type of systematic review evidence available to inform the optimal prescribing of statins and antihypertensives? A systematic umbrella review and evidence and gap map.BMJ Open. 2024 Feb 24;14(2):e072502. doi: 10.1136/bmjopen-2023-072502. BMJ Open. 2024. PMID: 38401904 Free PMC article.
-
Statin initiation and risk of incident kidney disease in patients with diabetes.CMAJ. 2023 May 29;195(21):E729-E738. doi: 10.1503/cmaj.230093. CMAJ. 2023. PMID: 37247880 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials